Professor Nicholas Buckley is a leading academic in Clinical Pharmacology at the University of Sydney and holds a Visiting Professor position at the University of Peradeniya, Sri Lanka. He serves as Research Director for the South Asian Clinical Toxicology Research Collaboration (SACTRC) and is a Consultant Clinical Pharmacologist & Toxicologist at the NSW Poisons Information Centre and Royal Prince Alfred Hospital. His work focuses on improving clinical toxicology practices, poison control policies, and understanding mechanisms of drug toxicity. Co-founder of SACTRC for agrochemical poisoning and snakebite research Chair of Australian Therapeutic Guidelines - Toxicology writing group Editorial roles in Clinical Toxicology, Drug Safety, and Australian Prescriber Research Interests include toxicovigilance, epidemiology of poisoning, acute kidney injury in poisoning/snakebite, pesticide safety interventions, antidote development, and pharmacoepidemiology of psychotropic drugs. His work combines clinical trials, population surveillance, and translational research. Scientific Contributions span 440+ peer-reviewed articles and 22 book chapters, with continuous funding since 2002. He has supervised over 20 higher degree students and leads international collaborations in low-and-middle-income countries through NIHR RIGHT4. Key Affiliations : Member of Charles Perkins Centre, Australian Medicines Handbook Editorial Advisory Board, and NIHR RIGHT4 programme.
Kyle Chapman serves as Associate Professor and Department Chair of Humanities and Social Sciences at Oregon Institute of Technology, where he has strengthened the Population Health Management program since joining in 2016. His work bridges sociological theory with practical healthcare applications through teaching and community-engaged research. His educational background includes a Doctor of Philosophy in Sociology with specializations in Medical Sociology and Gerontology from the University of Kansas (2016), a Master of Arts in Sociology from Texas Tech University (2011), and dual Bachelor of Arts degrees in Sociology and Mass Communication from Texas Tech University (2008). Dr. Chapman's research investigates social determinants of health with emphasis on aging, chronic disease, and health disparities. His work examines how socioeconomic factors shape physical and mental health outcomes across community and population levels, particularly focusing on rural healthcare challenges in Oregon. Recent projects analyze wildfire smoke impacts on hospital capacity, mental health among first responders, and barriers to healthcare access for vulnerable populations. His publication record reveals a consistent trajectory from foundational sociological studies toward applied public health research, with increasing focus on environmental health crises since 2020. The 2023-2025 articles demonstrate sophisticated integration of case-crossover methodologies with state health data to address Oregon's unique wildfire-related health challenges, while maintaining core interests in health behaviors and chronic disease management. As an educator, Dr. Chapman teaches medical sociology, research methods, and social inequality courses. His curriculum development work, including the 'Integrated Sociology Programs' framework, reflects commitment to preparing students for health sector careers through the Population Health Management program. Outside academic duties, he explores Pacific Northwest natural attractions with his family.
Professor Maria Eriksdotter is a leading academic in geriatrics and dementia research at the Karolinska Institutet , holding the Department of Neurobiology, Care Sciences and Society . She also serves as a Senior Consultant in Themes Inflammation and Ageing at Karolinska University Hospital Huddinge and previously as Dean of KI South (2019–2023). Her work spans translational research, clinical trials, and national registry development, with a focus on Alzheimer's disease, cholinergic therapies, and aging. Her research group pioneered NGF cell therapy for Alzheimer's patients, demonstrating safety and cognitive stabilization in clinical trials. She chairs the SveDem registry , tracking over 100,000 dementia patients to refine diagnostics and care. Studies from SveDem revealed mortality reduction with cholinesterase inhibitors and highlighted pandemic-era diagnostic delays. Recent publications analyze dementia subtypes , comorbidities , and precision medicine in neurodegeneration. Her work intersects neuroimaging , epidemiology , and public health policy , addressing ageism and improving geriatric care systems. Collaborations span Karolinska University Hospital , NSGene Inc , and international institutions.
Associate Professor Jenni Ilomaki holds a position at Monash University's Centre for Medicine Use and Safety. With expertise in clinical pharmacy, epidemiology, and public health, she leads a research group analyzing administrative claims data. Her work spans collaborations with governmental and non-governmental organizations globally, yielding over 150 peer-reviewed publications and $4 million in grants. She previously served as Chair of ASCEPT's Pharmacoepidemiology Special Interest Group and currently serves as Science Lead for the Monash Addiction Research Centre and Executive Editor of the British Journal of Clinical Pharmacology. Education includes a Bachelor of Science (Pharmacy) from the University of Kuopio (1999) and Master of Science (Pharmacy) from the University of Kuopio (2004). She completed a PhD in alcohol epidemiology at the University of Eastern Finland (2011) and a postdoc at the University of South Australia (2011-2014). Notable recognitions include Young Epidemiologist of the Year (2011) and the Ronald D. Mann Best Paper Award (2021). Key research focuses on quality use of medicines, medicine safety, large population studies, and innovative epidemiological methods. Major projects include developing clinical decision support tools for cardiovascular prevention, analyzing preventable hospitalizations in aged care, and investigating psychotropic medication trends in youth. Her work contributes to UN Sustainable Development Goals related to health equity and non-communicable disease reduction. Recent publications emphasize drug repurposing (e.g., SGLT2 inhibitors), opioid prescribing patterns, hip fracture outcomes, and dementia detection algorithms. She chairs multinational studies on stroke and myocardial infarction cost burdens, demonstrating interdisciplinary impact across pharmacology, epidemiology, and health economics.
Professor Timothy Chen is an academic at The University of Sydney , affiliated with the Brain and Mind Centre and the Charles Perkins Centre . He holds qualifications including a PhD, DipHPharm, BPharm, and professional certifications like MPS, MSHP, ARPharmS, FFIP. Research Focus : Medication management and safety, quality use of psychotropic medicines, and interprofessional collaboration in healthcare. Awards & Leadership : President of the Social and Administrative Section of the International Pharmaceutical Federation (FIP), Australian Award for University Teaching (2017), and key roles in global pharmacy policy. Key Contributions : Led the Home Medicines Review (HMR) program, supervised six PhD students to completion, and secured competitive research funding exceeding $2 million. His work spans clinical pharmacology, mental health, and geriatric pharmacy. Scientific Awards : Australian Award for University Teaching (2017) Elsevier Best Paper Award (2013) SUPRA Supervisor of the Year Finalist (2016) Distinguished Expert, Xi’an Jiaotong University (2017-2022) Current Research includes co-designing dementia care tools, validating Arabic medication burden instruments, and developing quality indicators for community pharmacy services. His team explores medication reconciliation, deprescribing, and mental health stigma reduction through pharmacist-led interventions.
Anne-Sofie Helvik is a Professor at the Norwegian University of Science and Technology (NTNU) within the Department of Public Health and Nursing . Her research focuses on quality of life, coping mechanisms, aging, impairment, and disabilities, with a particular emphasis on older adults. Email: anne-sofie.helvik@ntnu.no Location: Øya Helsehus, 153.03.001, Øya, Håkon Jarls gate 11 Her work spans multiple domains: Health Promotion: Central to her research is improving health outcomes in older populations. Substance Misuse: Investigates alcohol and drug use among older adults and its impact on health. Mental Health: Studies depression, pain, and dementia in aging populations. Sensory Function: Explores olfactory and hearing impairments in older adults. Healthcare Systems: Evaluates treatment, care, and postoperative follow-up in both pediatric and geriatric contexts. Her methodological approach combines both quantitative and qualitative research , with a strong emphasis on longitudinal studies and population-based analyses. Currently, she supervises two doctoral students: Heidi Sivertsen – Researching depression among older community residents. Ingrid Torvik Heian – Investigating olfactory functioning. Her research unit, Allmennmedisinsk Forsknings Enhet (AFE) , focuses on aging and health in older adults, accessible via NTNU’s aging and health page.
Lisa Kalisch Ellett is an Associate Professor at the University of South Australia, where she works at the Quality Use of Medicines and Pharmacy Research Centre. Her research focuses on improving medication use and health outcomes for Australians, with particular emphasis on studying adverse events associated with medicines. Professor Kalisch Ellett's research interests span several critical areas in pharmacy and medication safety. Her work examines quality use of medicines, adverse drug reactions, pharmacovigilance systems, and medication safety issues particularly affecting vulnerable populations such as older adults and people with dementia. She has conducted significant research on medicine shortages in Australia, including recent studies on ADHD medication shortages. Her work also explores polypharmacy issues, antipsychotic medication use in aged care, and innovative approaches to medication safety monitoring through digital health technologies. Analysis of Professor Kalisch Ellett's recent publications reveals a strong focus on practical applications of pharmacy research to improve real-world medication outcomes. Her work spans multiple methodologies including observational studies, database analyses, and consumer-focused research. Key trends in her research include examining medication safety in vulnerable populations, developing better systems for adverse drug reaction reporting, and addressing medication-related challenges in dementia care. Her research often has direct policy implications for improving medication use in the Australian healthcare system. President of the Australasian Pharmaceutical Science Association Member of the Pharmaceutical Society of Australia Professor Kalisch Ellett serves as president of the Australasian Pharmaceutical Science Association and is a member of the Pharmaceutical Society of Australia, indicating her active engagement with professional organizations in her field. While specific details about her advising and grant activities are limited in the available information, her extensive publication record suggests active research supervision and grant-funded projects. As a researcher at the Quality Use of Medicines and Pharmacy Research Centre, Professor Kalisch Ellett contributes to a collaborative research environment focused on optimizing medication use across various healthcare settings. Her work bridges clinical pharmacy practice with population health approaches to medication safety.
Nanbo Zhu is a Postdoctoral Researcher at Karolinska Institutet, jointly affiliated with the Department of Neurobiology, Care Sciences and Society (primary appointment until 2026) and the Department of Medical Epidemiology and Biostatistics (appointment until 2025). He conducts research within the Maria Eriksdotter research group (focused on clinical geriatrics) and Zheng Chang's psychiatric and pharmaco-epidemiology group. His research specializes in the intersection of mental health and chronic diseases , with emphasis on: Epidemiological patterns of mental illness in chronic kidney disease (CKD) patients Pharmacoepidemiology of psychiatric medications (antidepressants, ADHD drugs, benzodiazepines) Drug safety profiles in vulnerable populations including elderly and renal impairment patients Advanced methodologies like target trial emulation using registry data Zhu's publications demonstrate consistent focus on neuropsychiatric comorbidities in somatic conditions, pharmacotherapy outcomes, and population health in Chinese cohorts. His work frequently utilizes large-scale registries and emphasizes clinical implications of mental health management in chronic disease populations.
Ivana Bojanic is a full-time Researcher at the Faculty of Nursing and Health Sciences, Nord University, Norway. She holds a PhD in Medicine and Health Sciences from NTNU (2023) and has a background in pharmacy, medical biochemistry, and clinical experience as a laboratory head in Serbia. Her research focuses on mental health, drug use patterns, and cultural safety in healthcare, particularly among the Sami population and Arctic indigenous communities. She leads interdisciplinary projects funded by organizations like NordForsk and SANKS, addressing mental health in cardiovascular diseases/diabetes, digital health innovations for aging populations, and culturally safe healthcare services. Education: BSc in Pharmacy and Medical Biochemistry from the University of Belgrade, MSc in Pharmaceutical Health Prevention (University of Belgrade), PhD in Medicine and Health Sciences (NTNU). Teaching responsibilities include physiology, pharmacology, and quantitative research methods at bachelor's and master's levels. She supervises PhD and master's students and collaborates internationally on public health initiatives. Key Research Projects include: "Exploring Cultural Safety in Municipal Healthcare Services for Saami with Somatic Diseases" (Project Manager, NOK 267,000) "Promoting Healthy Aging of Sámi and Inuit Elders Through Co-Designed Digital Health Tool" (NordForsk, NOK 15 million) She is affiliated with research groups: Healthcare and Population Health, Pharmaceuticals and Pharmaceutical Management. Her work emphasizes co-design methods, quantitative/qualitative research, and health equity for marginalized groups such as the Sami population.
Ulrike Muench is an Associate Professor with tenure in the Department of Social and Behavioral Sciences at the UCSF School of Nursing, with affiliations at the Philip R. Lee Institute for Health Policy Studies and Healthforce Center. She specializes in nursing workforce dynamics, opioid policy, Medicare systems, and disparities in healthcare. Her research leverages large datasets like Medicare claims and the Medical Expenditure Panel Survey. Education & Training: MSN (2005) and PhD (2012) in Nursing from Yale University Postdoctoral Fellowship (2014) at Vanderbilt University School of Nursing Research Interests: Focuses on nurse practitioner roles, prescribing patterns in primary care/nursing homes, dementia care trajectories, and gender-based pay disparities in healthcare. Her work bridges health policy analysis with real-world clinical outcomes, aiming to inform equitable healthcare delivery systems. Awards: 2016 Academy Health New Investigator Award 2018 American Academy of Nursing Fellow 2019 UCSF School of Nursing Mentoring Award Grants & Advising: Leads studies funded by NIH and foundations, mentoring early-career researchers in health services research. Collaborates on projects addressing workforce distribution, rural-urban care disparities, and policy reform. Labs/Teams: Active in UCSF's Healthforce Center, focusing on healthcare workforce analytics and interdisciplinary policy development.
Dr. Thomas V. Caprio is a Professor at the University of Rochester Medical Center across multiple departments including Medicine (Geriatrics/Aging) , Dentistry , Psychiatry , Public Health Sciences , and SON Faculty . He serves as the Chief Medical Officer for UR Medicine Home Care and the Hospice Medical Director . A national leader in geriatrics and palliative care education, he directs the Finger Lakes Geriatric Education Center and has transformed age-friendly healthcare systems through workforce development and policy innovation. Key Research Areas: Aging and Geriatric Care End-of-Life Care Home Health Services Dementia and Caregiver Support Health Disparities Deprescribing and Medication Safety Scientific Awards & Recognitions: 2023 Faculty Academic Mentoring Award 2023 Walter M. Beatty Jr. Distinguished Membership Award 2023 Fellow of the Gerontological Society of America 2017 Fellow of the American Academy of Hospice and Palliative Medicine 2015 Fellow of the American Geriatrics Society 2013 Dean's Teaching Fellowship His publications focus on optimizing care transitions, reducing hospitalizations in nursing homes, improving oral health for dementia patients, and advancing age-friendly clinical practices. Current work emphasizes system-level transformation for age-friendly care, addressing health equity, and enhancing quality of life for older adults and their caregivers.
Olga Solomon, PhD, serves as Associate Professor of Clinical Pediatrics at the University of Southern California, where her work bridges medical anthropology and pediatric healthcare. She focuses on improving healthcare experiences for autistic children and their families, with particular attention to systemic disparities affecting racial and ethnic minority communities through community-engaged research methodologies. Her research centers on Autism Spectrum Disorder healthcare equity, examining how cultural, socioeconomic, and structural factors impact access to early intervention, diagnostic pathways, and treatment outcomes. Solomon employs ethnographic and narrative approaches to investigate parent-provider communication, community-based service navigation, and the social dimensions of conditions like sleep disorders, gastrointestinal issues, and obesity in autistic youth. Her work consistently highlights the intersection of disability studies with health services research. Analysis of Solomon's publication trajectory reveals sustained focus on racial and ethnic disparities in autism care, with increasing emphasis on community-academic partnerships and participatory methodologies. Her research spans clinical domains including pediatric obesity management, behavioral health interventions, and diagnostic processes, always contextualized within broader frameworks of health equity and social justice. Recent work demonstrates methodological innovation through mixed-methods approaches that center community perspectives.
Professor Woosung Sohn is Chair of Population Oral Health at the University of Sydney School of Dentistry, where he leads research and teaching in population oral health and collaborates with NSW Health and local health districts. He previously served as Director of the Advanced Specialty Education Program in Dental Public Health and Associate Professor at Boston University Goldman School of Dental Medicine, where he maintains an adjunct appointment. His education includes DDS, MS, and PhD in Preventive Dentistry from Yonsei University, Seoul, Korea, and Doctor of Public Health (DrPH) in Epidemiology from the University of Michigan School of Public Health. He is a Diplomat of the American Board of Dental Public Health. Sohn's research primarily focuses on reducing oral health disparities through understanding factors related to oral disease and improving access to dental care, particularly for underserved populations. His work involves analysis of large datasets including dental claims databases and national surveys, evaluation of state-level oral health policy, and research on children's water consumption patterns related to water fluoridation. His early publications provided key evidence for the 2015 adjustment of USPHS recommendation of optimum fluoride concentration in drinking water to 0.7 ppmF. His recent publications (2023-2025) demonstrate continued focus on health disparities, with particular attention to Indigenous populations in Australia, culturally and linguistically diverse communities, rural health access issues, obesity-related dental care challenges, and antibiotic prescribing patterns in dentistry. His work spans epidemiological studies, policy evaluations, and intervention development. Fellow, ADEA Leadership Institution, American Dental Education Association (2009) IADR Aubrey Sheiham Award for Distinguished Research in Dental Public Health Sciences (2009) Research Fellowship, Oak Ridge Institute for Science and Education (ORISE), CDC (2008) Sohn has directed Advanced Education Programs in Dental Public Health including Residency programs, Masters' in Science (MS), and Doctor of Science in Dentistry (DScD). In 2015, he received a $2.8 million HRSA grant for a combined DPH-Pediatric Dentistry residency training program. He serves as Editor of the Journal of Evidence-Based Dental Practice and on the editorial board of the Journal of Public Health Dentistry. His teaching includes Oral Epidemiology, Dental Public Health, and Evidence-based Dentistry, with a focus on critical thinking and evidence-based practice.
Alayne D. Markland, DO, MSc is a tenured Professor and holds the D. Kevin Barnes, MD and Dottie Barnes Presidential Endowed Chair in the Division of Geriatrics within the Department of Internal Medicine at the University of Utah. She serves as Executive Director of the Center on Aging and is an investigator at the Salt Lake City VA Health Care System's Geriatric Research, Educational, and Clinical Center (GRECC). Dr. Markland is nationally and internationally recognized for her expertise in lower urinary tract disorders, women's health, and aging. Dr. Markland received her D.O. from the University of North Texas Health Science Center, College of Osteopathic Medicine, a B.S. in Biology from Southwestern University, an M.Sc. in Clinical Investigation from the University of Texas Health Science Center at San Antonio, and completed her Geriatric Medicine Fellowship at the same institution. She also completed her Internal Medicine Residency at the University of California, Davis Medical Center. Her research focuses on optimizing community-based life functioning through the prevention and treatment of geriatric syndromes, with specific emphasis on lower urinary tract symptoms and incontinence. Dr. Markland's work spans population-based studies, multicenter clinical trials, and implementation studies to increase access to incontinence care using technology. She has published over 190 peer-reviewed publications with more than 10,000 citations and brings 20 years of clinical experience treating adults with lower urinary tract symptoms. Analysis of Dr. Markland's recent publications reveals a strong focus on bladder health across the lifespan, particularly women's bladder health, urinary incontinence, and the relationship between mental health and lower urinary tract symptoms. Her work increasingly incorporates mobile health technology to improve access to care and examines social determinants of health as they relate to bladder conditions. D. Kevin Barnes, MD and Dottie Barnes Presidential Endowed Chair NIA K24 Mid-career Award in Aging Research ("Research and Mentoring Program in Improving Access to Incontinence Care for Older Adults") Continual NIH and VA funding throughout her career Dr. Markland serves as Principal Investigator on multiple significant grants including a NIDDK-funded U01 grant, two NIDDK-funded R01 grants, and an implementation consortium grant from AHRQ/DHHS. She actively mentors early-stage investigators through her NIA K24 award and has served as an ad-hoc member on NIH and VA study sections. Her research program encompasses over 190 peer-reviewed publications with more than 10,000 citations according to Google Scholar. As Executive Director of the Center on Aging at the University of Utah, Dr. Markland leads interdisciplinary research initiatives focused on aging-related conditions. Her work with the Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium represents a major collaborative effort to understand bladder health across the female lifespan. She also collaborates extensively with the Geriatric Research, Educational, and Clinical Center (GRECC) at the Salt Lake City VA, where she investigates interventions to improve care for older veterans.
Associate Professor Betty Chan is an Emergency Physician, Clinical Toxicologist, and clinical researcher at the University of New South Wales. She serves as Head of the Discipline of Critical Care at UNSW and Head of the Clinical Toxicology Unit at the Prince of Wales Hospital. Additionally, she works as a VMO toxicologist at the New South Wales Poisons Information Centre and serves on the editorial board of Clinical Toxicology and the SES LHD Human Research and Ethics Committee. Dr. Chan completed her Emergency Medicine training in 1990 and earned her PhD in toxicology from the University of Sydney in 1997. Her academic credentials include MBBS, FACEM, PhD, and MDiv. Her primary research interests focus on translational research in Clinical Toxicology, Harm Reduction, Antidotes, Medical Education, and the application of Artificial Intelligence in medical education. Specific areas of investigation include digoxin overdose management, dihydropyridine toxicity, methotrexate intoxication and antidotes, safe opioid use and prescription practices, development of clinical decision rules for non-traumatic CT head imaging, herbicide toxicity (including paraquat, bromoxynil, and MCPA), acute behavioral disturbance treatment, sodium channel blocker toxicity, lithium poisoning, cognitive assessment following overdose and shift work, tapentadol prescription trends and poisoning, and adherence to clinical guidelines for specific poisonings. Analysis of Dr. Chan's recent publications reveals a strong focus on clinical toxicology with particular emphasis on drug overdose management, antidote efficacy, and patient safety. Her work spans multiple areas including cardiovascular toxicology (digoxin, calcium channel blockers), hepatotoxicity (acetaminophen), neurotoxicology (anticholinergics, antipsychotics), and harm reduction strategies (naloxone distribution). Many of her studies are part of the Australian Toxicology Monitoring (ATOM) research program, demonstrating her commitment to evidence-based toxicology practice. 2016 John Gilroy Potts Award at the ACEM conference for the paper 'The Safety and Effectiveness of Droperidol for Sedation of Acute Behavioural Disturbance in the Emergency Department' 2019 Best Scientific presentation at the 39th Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) on 'Using EXTRIP criteria as indications for Extracorporeal Treatment in Lithium Poisoning.' As Head of the Discipline of Critical Care at UNSW, Dr. Chan leads the curriculum and teaching for medical students in Emergency Medicine, Anesthesia, and Intensive Care. She also oversees the teaching curriculum and supervision of toxicology registrars and fellows as head of the Clinical Toxicology Unit. Her research supervision includes ILP Honours projects focused on the Poisons Information Centre clinical Toxicology referral Study (PICTS) and adherence to clinical guidelines for specific poisonings. She has been principal investigator for numerous clinical research projects in toxicology, including the multi-center Australian Toxicology Monitoring (ATOM) Study initiated in 2013 and the Translational Australian Clinical Toxicology (TACT) program funded by NHMRC grants. Dr. Chan's work has significantly impacted clinical practice, particularly in demonstrating that patients with digoxin poisoning can be managed safely with small, titrated doses of digoxin antibody, and establishing guidelines for folinic acid use in methotrexate poisoning. Her research on cognitive impairment following sedative overdose has informed recommendations about post-overdose activity restrictions.
